Search results
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk - BusinessWorld...
BusinessWorld· 4 days agoGSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding...
Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
Medscape· 5 days agoPatients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
Potential blockbuster asthma drug met goals in trials, GSK says
Morningstar· 3 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both trials of depemokimab ...
GSK Discovered Vaccine That Protects Against RSV, Paul Singer
Dealbreaker· 3 days agoPaul Singer may or may not have become a nicer person over the last few years, but that doesn’t mean...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 1 day agoA biotechnology firm with operations in Durham is working on a major deal with with Eli Lilly and...
Infinant Health Appoints New Team Members to assist with Drug Development
FOX21 Colorado Springs· 2 days agoInfinant Health, a privately-held company focused on changing the trajectory of human health by supporting the development and restoration of the immune system via the gut microbiome, announces ...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters· 4 days ago, opens new tab has been sued by an independent Connecticut laboratory that accused the drugmaker of...
Explainer-What to know about bird flu in dairy cows and the risk to humans By Reuters
Investing.com· 2 days agoCHICAGO (Reuters) -A second human case of bird flu was confirmed in a dairy worker in Michigan, U.S....
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk By Reuters
Investing.com· 4 days agoIn a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims...
Tempus AI files to go public
Modern Healthcare· 3 days agoTempus declined to comment but plans for its stock to trade on the the Nasdaq Global Select Market under the ticker TEM. Tempus' database includes 7.7 million clinical records and is used by ...
